FTC secures partial win against AbbVie

The Federal Trade Commission (FTC) has secured a partial victory in its competition case against life sciences company AbbVie.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Abbott’s $25bn St. Jude acquisition would be anti-competitive, says FTC

24 February 2017 The Federal Trade Commission has found after a public comment period that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical would probably be anti-competitive.

Americas

AbbVie and Besins to pay FTC $448m in sham litigation case

2 July 2018 Pharmaceutical companies AbbVie and Besins Healthcare have been ordered to pay the US Federal Trade Commission $448 million for using “sham litigation” to block access to generic versions of a testosterone drug.

Americas

FTC’s $448m AbbVie win overturned

2 October 2020 A US appeals court has cancelled a $448 million antitrust bill for AbbVie, in a blow for the US Federal Trade Commission.

More on this story

Americas

Abbott’s $25bn St. Jude acquisition would be anti-competitive, says FTC

24 February 2017 The Federal Trade Commission has found after a public comment period that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical would probably be anti-competitive.

Americas

AbbVie and Besins to pay FTC $448m in sham litigation case

Americas

FTC’s $448m AbbVie win overturned

2 October 2020 A US appeals court has cancelled a $448 million antitrust bill for AbbVie, in a blow for the US Federal Trade Commission.

More on this story

Americas

Abbott’s $25bn St. Jude acquisition would be anti-competitive, says FTC

24 February 2017 The Federal Trade Commission has found after a public comment period that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical would probably be anti-competitive.

Americas

AbbVie and Besins to pay FTC $448m in sham litigation case

Americas

FTC’s $448m AbbVie win overturned

2 October 2020 A US appeals court has cancelled a $448 million antitrust bill for AbbVie, in a blow for the US Federal Trade Commission.